Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 1, 2009, Pages 234-243

  Li, Jiang ^a   Wilson, Annette ^a   Gao, Xiang ^a   Kuruba, Ramalinga ^a   Liu, Youhua ^b   Poloyac, Samuel ^a   Pitt, Bruce ^c   Xie, Wen ^a   Li, Song ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; AMINO ACID TRANSPORTER; DIMETHYLARGININASE; DIMETHYLARGININE DIMETHYLAMINOHYDROLASE 1; FARNESOID X RECEPTOR; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMIDOHYDROLASES; ANIMALS; ARGININE; CATIONIC AMINO ACID TRANSPORTER 1; CELL LINE; CELLS, CULTURED; HAPLORHINI; HUMANS; ISOXAZOLES; KIDNEY; LIVER; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 70349306439     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.153510     Document Type: Article

References (40)

1. Achan V, Tran CT, Arrigoni F, Whitley GS, Leiper JM, and Vallance P (2002) all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase. Circ Res 90:764-769. (Pubitemid 34633891)
2. Anisfeld AM, Kast-Woelbern HR, Lee H, Zhang Y, Lee FY, and Edwards PA (2005) Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling. J Lipid Res 46:458-468. (Pubitemid 43109782)
3. Baylis C (2006) Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2:209-220. (Pubitemid 43787287)
4. Bertolotti M, Gabbi C, Anzivino C, Carulli L, Loria P, and Carulli N (2008) Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: insights from evidence on hepatic cholesterol degradation and gallstone disease in humans. Curr Med Chem 15:2271-2284.
5. Bishop-Bailey D, Walsh DT, and Warner TD (2004) Expression and activation of the farnesoid X receptor in the vasculature. Proc Natl Acad Sci U S A 101:3668-3673. (Pubitemid 38338252)
6. Böger RH (2003) The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 59:824-833. (Pubitemid 38366238)
7. Bulau P, Zakrzewicz D, Kitowska K, Leiper J, Gunther A, Grimminger F, and Eickelberg O (2007) Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. Am J Physiol Lung Cell Mol Physiol 292:L18-L24. (Pubitemid 46103426)
8. Cariou B and Staels B (2007) FXR: a promising target for the metabolic syndrome? Trends Pharmacol Sci 28:236-243. (Pubitemid 46661001)
9. Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, et al. (2006) The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 281:11039-11049. (Pubitemid 43855527)
10. Dudzinski DM, Igarashi J, Greif D, and Michel T (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 46:235-276. (Pubitemid 43271190)
11. Echchgadda I, Song CS, Roy AK, and Chatterjee B (2004) Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65:720-729. (Pubitemid 38264040)
12. Eloranta JJ and Kullak-Ublick GA (2005) Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 433:397-412. (Pubitemid 39592794)
13. Gary JD and Clarke S (1998) RNA and protein interactions modulated by protein arginine methylation. Prog Nucleic Acid Res Mol Biol 61:65-131.
14. Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, and Itoh H (2007) Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginine dimethylaminohydrolase 2. Circ Res 101:e2-e10. (Pubitemid 47196589)
15. Hatzoglou M, Fernandez J, Yaman I, and Closs E (2004) Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu Rev Nutr 24:377-399. (Pubitemid 38938797)
16. He F, Li J, Mu Y, Kuruba R, Ma Z, Wilson A, Alber S, Jiang Y, Stevens T, Watkins S, et al. (2006) Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells. Circ Res 98:192-199. (Pubitemid 43755350)
17. Hu T, Chouinard M, Cox AL, Sipes P, Marcelo M, Ficorilli J, Li S, Gao H, Ryan TP, Michael MD, et al. (2006) Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation. J Biol Chem 281:39831-39838. (Pubitemid 46041786)
18. Jung D, Mangelsdorf DJ, and Meyer UA (2006) Pregnane X receptor is a target of farnesoid X receptor. J Biol Chem 281:19081-19091.
19. Kielstein JT and Zoccali C (2008) Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 17:609-615.
20. Kocarek TA, Shenoy SD, Mercer-Haines NA, and Runge-Morris M (2002) Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes. J Pharmacol Toxicol Methods 47:177-187.
21. Leiper J, Nandi M, Torondel B, Murray-Rust J, Malaki M, O'Hara B, Rossiter S, Anthony S, Madhani M, Selwood D, et al.(2007) Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 13:198-203. (Pubitemid 46245768)
22. Li J, Wilson A, Kuruba R, Zhang Q, Gao X, He F, Zhang LM, Pitt BR, Xie W, and Li S (2008) FXR-mediated regulation of eNOS expression in vascular endothelial cells. Cardiovasc Res 77:169-177. (Pubitemid 351195146)
23. Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, Creech KL, Moore LB, Wilson JG, Lewis MC, et al. (2000) Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 43:2971-2974. (Pubitemid 30626755)
24. Mann GE, Yudilevich DL, and Sobrevia L (2003) Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183-252.
25. Martens-Lobenhoffer J, Krug O, and Bode-Böger SM (2004) Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique. J Mass Spectrom 39:1287-1294. (Pubitemid 39545978)
26. Monsalve E, Oviedo PJ, García-Pérez MA, Tarín JJ, Cano A, and Hermenegildo C (2007) Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells. Cardiovasc Res 73:66-72. (Pubitemid 44937184)
27. Palm F, Onozato ML, Luo Z, and Wilcox CS (2007) Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293:H3227-H3245. (Pubitemid 350230862)
28. Podvinec M, Kaufmann MR, Handschin C, and Meyer UA (2002) NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol 16:1269-1279. (Pubitemid 34621075)
29. Reade MC, Clark MF, Young JD, and Boyd CA (2002) Increased cationic amino acid flux through a newly expressed transporter in cells overproducing nitric oxide from patients with septic shock. Clin Sci 102:645-650.
30. Schulz E, Jansen T, Wenzel P, Daiber A, and Münzel T (2008) Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10:1115-1126.
31. Searles CD (2006) Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression. Am J Physiol Cell Physiol 291:C803-C816. (Pubitemid 44771801)
32. Shaul PW (2002) Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749-774. (Pubitemid 34259248)
33. Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, and Van den Berghe G (2005) Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33:504-510. (Pubitemid 40365549)
34. Stamler JS and Feelisch M (1996) Preparation and detection of S-nitrosothiols, in Methods in Nitric Oxide Research (Feelisch M and Stamler JS eds) pp 521-539, John Wiley & Sons, New York.
35. Stuehr DJ (1997) Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol 37:339-359. (Pubitemid 27238880)
36. Tain YL and Baylis C (2007) Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney Int 72:886-889.
37. Teerlink T (2005) ADMA metabolism and clearance. Vasc Med 10:S73-S81.
38. Vallance P and Leiper J (2004) Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 24:1023-1030. (Pubitemid 38737826)
39. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, and Auwerx J (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113:1408-1418. (Pubitemid 39071696)
40. Wilson Tang WH, Tong W, Shrestha K, Wang Z, Levison BS, Delfraino B, Hu B, Troughton RW, Klein AL, and Hazen SL (2008) Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. Eur Heart J 29:2506-2513.